phenoxazinone has been researched along with lysine in 1 studies
| Studies (phenoxazinone) | Trials (phenoxazinone) | Recent Studies (post-2010) (phenoxazinone) | Studies (lysine) | Trials (lysine) | Recent Studies (post-2010) (lysine) |
|---|---|---|---|---|---|
| 55 | 0 | 17 | 37,449 | 622 | 11,213 |
| Protein | Taxonomy | phenoxazinone (IC50) | lysine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 158 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolognese, A; Cerchia, C; Cioce, A; Lavecchia, A; Manfra, M; Pedatella, S | 1 |
1 other study(ies) available for phenoxazinone and lysine
| Article | Year |
|---|---|
Antitumor agents 7. Synthesis, antiproliferative activity and molecular modeling of new l-lysine-conjugated pyridophenoxazinones as potent DNA-binding ligands and topoisomerase IIα inhibitors.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Ligands; Linear Models; Lysine; Models, Molecular; Molecular Structure; Oxazines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2020 |